Biotech Digest – INSM Reports Positive Data, MRK Gets EC Approval, LCI Receives FDA Approval

Oramed Pharmaceuticals reported the successful conclusion of its meeting with the FDA with regard to its drug candidate ORMD-0801. Insmed (INSM) stock jumped over 100 percent in the pre-market session.